Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Comment by Possibleidiot01on Nov 08, 2022 12:19pm
146 Views
Post# 35082372

RE:Top Pick

RE:Top Pick
TOP PICK
It is the third largest pharmacy chain in Canada. Is mostly in the rural communities and has a strategy to consolidate the fragmented industry in these areas and grow the top line. It is both a defensive and a growth stock. It has new revenue sources since pharrmacies can prescribe more medications now as well as offer more services. After its IPO 18 months ago, it soared then fell back to the low $20's, close to its IPO price. Had very good results a few weeks ago. It has doubled its revenue to $830 and EBITA to $100. Has good free cash flow and increased margins. There has been significant insider buying in the past few months. A safe way to play the health care system. Buy 6, Hold 3, Sell 0 (Analysts’ price target is $29.56)
Healthcare
$23.420
Owned

<< Previous
Bullboard Posts
Next >>